Ironwood Pharmaceuticals, Inc. (IRWD) — Analyst outlook / Analyst consensus target is. Based on 30 analyst ratings, the consensus is bullish — 11 Buy, 16 Hold, 3 Sell.
The consensus price target is $4.80 (low: $3.70, high: $5.70), representing an upside of 18.8% from the current price $4.04.
Analysts estimate Earnings Per Share (EPS) of $0.08 and revenue of $0.36B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.01 vs est $0.08 (missed -87.1%). 2025: actual $0.15 vs est $0.12 (beat +28.6%). Analyst accuracy: 0%.
IRWD Stock — 12-Month Price Forecast
$4.80
▲ +18.81% Upside
Average Price Target
Based on 30 Wall Street analysts offering 12-month price targets for Ironwood Pharmaceuticals, Inc., the average price target is $4.80, with a high forecast of $5.70, and a low forecast of $3.70.
The average price target represents a +18.81% change from the last price of $4.04.
Highest Price Target
$5.70
Average Price Target
$4.80
Lowest Price Target
$3.70
IRWD Analyst Ratings
Hold
Based on 30 analysts giving stock ratings to Ironwood Pharmaceuticals, Inc. in the past 3 months
EPS Estimates — IRWD
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.01
vs Est $0.08
▼ 676.8% off
2025
Actual $0.15
vs Est $0.12
▲ 22.2% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.
Revenue Estimates — IRWD
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.351B
vs Est $0.355B
▼ 0.9% off
2025
Actual $0.296B
vs Est $0.299B
▼ 1.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
